2009 Vienna - European Society of Human Genetics
2009 Vienna - European Society of Human Genetics
2009 Vienna - European Society of Human Genetics
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Prenatal and perinatal genetics<br />
24 h was equal to 3,1+3,09 % and they were detected only in the group<br />
A, whereas after 48 h they were represented in both A (36,1+16,01 %)<br />
and in M groups (10,5+4,20 %) (P 0.05) after 72 h incubation. No 3 rd generations cells<br />
have been registered in both groups.<br />
These results are consistent with some previous data which postulate<br />
the duration <strong>of</strong> one complete cell cycle <strong>of</strong> CTB equal to approximately<br />
36 h. However proliferative capacity in vivo <strong>of</strong> CTB cells from missed<br />
abortion is reduced if compared to this one <strong>of</strong> progressive normal pregnancy.<br />
P05.08<br />
Relationship <strong>of</strong> circulating cell-free DNA levels to cell-free fetal<br />
DNA levels, clinical characteristics and laboratory parameters in<br />
preeclampsia<br />
L. Lazar, B. Nagy, A. Molvarec, J. Rigó Jr.;<br />
Semmelweis University, Budapest, Hungary.<br />
Objective: Elevated amounts <strong>of</strong> circulating DNA in maternal plasma<br />
have been detected in pregnancies complicated by preeclampsia. We<br />
attempted to confirm this and simultaneously examined whether increased<br />
circulating cell-free DNA levels are related to the clinical characteristics<br />
and laboratory parameters <strong>of</strong> preeclamptic patients.<br />
Study design: Circulating DNA was measured by real-time PCR in<br />
plasma samples obtained from 67 women with preeclampsia and 70<br />
normotensive pregnant women. Standard laboratory parameters and<br />
C-reactive protein levels were determined by an autoanalyzer. Plasma<br />
von Willebrand factor antigen levels were quantified by ELISA, while<br />
plasma fibronectin concentration by nephelometry. Plasma malondialdehyde<br />
levels were measured by the thiobarbituric acid-based colorimetric<br />
assay.<br />
Results: We confirmed that circulating total free and fetal DNA levels<br />
are significantly elevated in pregnancies complicated by preeclampsia<br />
(median: 11.395 vs. 32.460 and 0.001 vs. 0.086 pg/ul; P < .001). The<br />
quantity <strong>of</strong> total plasma-free DNA did not correlate with most <strong>of</strong> the<br />
laboratory parameters, except for serum aspartate aminotransferase<br />
and alanine aminotransferase activities (correlation coefficient: 0.31;<br />
P=0.012 and 0.46; P1y).<br />
Study <strong>of</strong> the common mutations (PCR-ASO) and R426H (7% virilizing<br />
forms in Spain) together with genomic DNA analysis for hybrid deletions/large<br />
gene conversions to detect hemizygosity, semiquantitative<br />
primer-extension for gene duplications carrying Q318X, microsatellite<br />
typing to detect unknown homozygosity for rare alleles (complementary<br />
sequencing).<br />
Results: CYP21A2 segregated mutant alleles were detected in 13 patients:<br />
3 compound heterozygous with I172N and null alleles (3 boys),<br />
8 compound heterozygous with severe mutations and V281L, and 2<br />
with two mild alleles. Sustained 17OHP levels confirmed CAH-21OHD<br />
diagnosis <strong>of</strong> these “neonatal cryptic forms”. In 43, mutations were discarded<br />
in both alleles and a carrier situation was detected in 4 (655G,<br />
655G+Q318X,V281L, P453S). The normal variant Q318X in gene duplicated<br />
alleles was detected in 2 additional samples. Absence <strong>of</strong> clinical<br />
signs and normalization <strong>of</strong> 17OHP levels, in these remaining 45<br />
cases, discarded the deficiency.<br />
Conclusion: CYP21A2 genotyping proved useful as a second-tier<br />
analysis. The deficiency was discarded in all the negative patients and<br />
carriers. The genotypes in those CYP21A2 positive patients allowed<br />
to discard a severe deficiency and were compatible with mild forms in<br />
boys and girls (compound heterozygous with V281L) or virilizing forms<br />
in boys (compound heterozygous with I172N).<br />
P05.11<br />
Prenatal diagnosis <strong>of</strong> Dandy Walker malformation: case report<br />
D. F. Albu, C. C. Albu, M. Dumitrescu, E. Severin;<br />
“Carol Davila” Univ Med Pharm, Bucharest, Romania.<br />
A 35-year-old pregnant Caucasian female was referred at 20 weeks <strong>of</strong><br />
gestation for a routine prenatal ultrasound. Fetal monitoring was made<br />
by ultrasound scans for fetal growth, congenital malformations, and<br />
amniotic fluid volume. Information about family medical history was collected<br />
too. Amniotic fluid samples were taken to perform prenatal cytogenetic<br />
diagnosis because sometimes Dandy Walker malformation is<br />
associated with chromosome aberrations. The woman was tested for<br />
TORCH. Results: Ultrasound examination revealed a singleton pregnancy<br />
with cerebellar malformation and associated anomalies: ventriculomegaly,<br />
meningocele and hydrocephaly. Karyotype indicated a<br />
normal cytogenetic female: 46, xx. No evidence <strong>of</strong> an infectious origin<br />
was found. The pregnancy was terminated at 25 weeks <strong>of</strong> gestation<br />
Autopsy findings confirmed the ultrasound diagnosis. Conclusions: a<br />
sporadic case with Dandy Walker malformation was described; prenatal<br />
ultrasound disclosed a positive result useful for pregnancy management<br />
and counseling for abortion.<br />
P05.12<br />
importance <strong>of</strong> Routine Ultrasonography in Detecting Fetal<br />
Karyotype Abnormalities in Low Risk Pregnancies<br />
A. I. Narin 1 , Z. Yilmaz 1 , D. Eroglu 2 , F. Yanik 2 , F. I. Sahin 1 ;<br />
1 Baskent University Faculty <strong>of</strong> Medicine Department <strong>of</strong> Medical <strong>Genetics</strong>, Ankara,<br />
Turkey, 2 Baskent University Faculty <strong>of</strong> Medicine Department <strong>of</strong> Obstetrics